Evidence map›Paper›PMID 31264851›Full record

ArticleACS infectious diseases2019

Dual Inhibition of

Seoung-Ryoung Choi, Bradley E Britigan, Prabagaran Narayanasamy

Abstract read
In one paragraph

Article in ACS infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. A novel approach to combatMicrobiology spectrum · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Fullerene Gallium Phosphonate Shows Antimycobacterial Effect AgainstInternational journal of molecular sciences · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Seoung-Ryoung ChoiDepartment of Pathology and Microbiology, College of Medicine , University of Nebraska Medical Center , 985900 Nebraska Medical Center , Omaha , Nebraska 68198 , United States.
Bradley E BritiganDepartment of Pathology and Microbiology, College of Medicine , University of Nebraska Medical Center , 985900 Nebraska Medical Center , Omaha , Nebraska 68198 , United States.
Prabagaran NarayanasamyDepartment of Pathology and Microbiology, College of Medicine , University of Nebraska Medical Center , 985900 Nebraska Medical Center , Omaha , Nebraska 68198 , United States.ORCID 0000-0002-9617-5555
University of Nebraska Medical Center · US

Funding

Development of Gallium-Based Therapies for Pulmonary Mycobacterial InfectionsI01BX002504 · VA · OMAHA VA MEDICAL CENTER · PI BRITIGAN, BRADLEY E · 2015 to 2018
–
BLRD VA I01 BX002504
6 · The paper itself

Abstract

Iron- and heme-uptake pathways and metabolism are promising targets for the development of new antimicrobial agents, as their disruption would lead to nutritional iron starvation and inhibition of bacterial growth. Salts of gallium(III) (Ga), an iron mimetic metal, disrupt iron-dependent biological processes by binding iron-utilizing proteins and competing with iron for uptake by bacterial siderophore-mediated iron uptake systems. Ga porphyrins, heme mimetic complexes, disrupt heme-utilizing hemoproteins. Because Ga(NO

Indexed as

Acinetobacter baumanniiBacteriaBiofilmsDrug SynergismGalliumIronKlebsiella pneumoniaeMetabolic Networks and PathwaysMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsPorphyrinsPseudomonas aeruginosaGalliumgallium nitrateIronPorphyrinsdual inhibitionESKAPE pathogensgallium complexiron metabolism

Identifiers

PMID31264851
PMCPMC12188613
OpenAlexW2954935857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.